Dreamspan Product Innovation - From Vision to Store Shelf

For fiscal 2006, Zicam nearly reached the magical $100 million revenue figure with sales of $96.2 million. Over the past five years, Zicam has had a compound annual growth rate of over 43%, which places their revenue growth among the top performing Nasdaq listed companies. Additionally, Zicam® branded products’ growth at retail continues to outpace the cough and cold category.